1. Home
  2. IRIX vs TENX Comparison

IRIX vs TENX Comparison

Compare IRIX & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRIX
  • TENX
  • Stock Information
  • Founded
  • IRIX 1989
  • TENX 1967
  • Country
  • IRIX United States
  • TENX United States
  • Employees
  • IRIX N/A
  • TENX N/A
  • Industry
  • IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • TENX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IRIX Health Care
  • TENX Health Care
  • Exchange
  • IRIX Nasdaq
  • TENX Nasdaq
  • Market Cap
  • IRIX 16.5M
  • TENX 21.7M
  • IPO Year
  • IRIX 1996
  • TENX N/A
  • Fundamental
  • Price
  • IRIX $1.01
  • TENX $5.32
  • Analyst Decision
  • IRIX Hold
  • TENX Strong Buy
  • Analyst Count
  • IRIX 1
  • TENX 3
  • Target Price
  • IRIX $2.00
  • TENX $16.00
  • AVG Volume (30 Days)
  • IRIX 102.1K
  • TENX 23.1K
  • Earning Date
  • IRIX 05-13-2025
  • TENX 05-13-2025
  • Dividend Yield
  • IRIX N/A
  • TENX N/A
  • EPS Growth
  • IRIX N/A
  • TENX N/A
  • EPS
  • IRIX N/A
  • TENX N/A
  • Revenue
  • IRIX $48,669,000.00
  • TENX N/A
  • Revenue This Year
  • IRIX $9.61
  • TENX N/A
  • Revenue Next Year
  • IRIX N/A
  • TENX N/A
  • P/E Ratio
  • IRIX N/A
  • TENX N/A
  • Revenue Growth
  • IRIX N/A
  • TENX N/A
  • 52 Week Low
  • IRIX $0.78
  • TENX $2.77
  • 52 Week High
  • IRIX $3.29
  • TENX $7.89
  • Technical
  • Relative Strength Index (RSI)
  • IRIX 49.06
  • TENX 35.01
  • Support Level
  • IRIX $0.79
  • TENX $5.36
  • Resistance Level
  • IRIX $1.13
  • TENX $5.75
  • Average True Range (ATR)
  • IRIX 0.07
  • TENX 0.39
  • MACD
  • IRIX 0.03
  • TENX -0.06
  • Stochastic Oscillator
  • IRIX 64.79
  • TENX 10.56

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

Share on Social Networks: